Management of Irritable Bowel Syndrome (IBS) in Ayurveda: A Case Report
Keywords:
Grahani, Irritable Bowel Syndrome, Agni, Basti, Shirodhara, Ayurvedic MedicineAbstract
Introduction: Irritable Bowel Syndrome is a chronic functional bowel disease characterized by symptoms of abdominal pain and/or discomfort associated with altered bowel habits. Though some biomarkers for IBS have been developed, studies are still being carried out to increase their sensitivity, specificity and validity to differentiate IBS and subtypes of IBS. Laxatives, prosecretory agents, antispasmodics, tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) are used for its treatment in conventional medicinal systems. IBS can be correlated with Grahani in Ayurveda based on its symptomatology. In Grahani disease, Agni (digestive factors) of the body is weakened due to which there is abnormality in digestion, assimilation of foods and bowel movements.
Case Report: In this case report, we have made an attempt to treat a male patient of 38 years having the symptoms ofMuhurdrava, Udarashooland weiMuhurbaddha ght loss. Patient diagnosed with Grahani/ IBS was treated with few oral medicines like Bilvadi Vati, Panchamrit Parpati, Panchakarma procedures; Basti (therapeutic enema), Shirodhara (therapeutic oil-streaming over forehead) and Ayurveda psychological counselling. At the end of 51 days of treatment the patient showed 75% relief in passing of loose and constipated stool, 75% relief in distension of abdomen, 100% improvement in appetite and passing of mucus in stool.
References
Gastrointestinal Society. IBS Global Impact Report: uncovering the true burden of irritable bowel syndrome (IBS) on people’s lives. [Internet]. 2014 [cited on 2021 Apr 19]; Available from: https://badgut.org/wpcontent/uploads/IBS-Global- Impact-Report.pdf
El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. [Internet]. 2015. [cited on 2021 Apr 19];21(25):7621-7636 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491952/ doi: 10.3748/wjg.v21.i25.7621.
Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. [Internet]. 2010 cited on 2021 Apr 19];7(3):163-73. Available from: https://pubmed.ncbi.nlm.nih.gov/20101257/ doi: 10.1038/nrgastro.2010.4.
Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers. [Internet]. 2016[cited on 2021 Apr 19];2:16014. Available from: https://pubmed.ncbi.nlm.nih.gov/27159638/ doi: 10.1038/nrdp.2016.14.
Chira A, Dumitrascu DL. Serum BioMarkers for Irritable Bowel Syndrome. Cajul Medical. [Internet]. 2015. [cited on 2021 Apr 19];88(3);258-64. Available from: https://www.researchgate.net/publication/282071036_Serum_biomarkers_for_Irritable_bowel_syndrome. DOI 10.15386/CJMED-496.
Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. [Internet]. 2014. [cited on 2021 Apr 19];6:71-80. Available from: https://pubmed.ncbi.nlm.nih.gov/24523597/ doi: 10.2147/CLEP.S40245.
Hungin APS, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther. [Internet]. 2003. [cited on 2021 Apr 19];17:643–50. Available from: https://pubmed.ncbi.nlm.nih.gov/12641512/ doi: 10.1046/j.1365-2036.2003.01456.x.
The National Institute for Health and Clinical Excellence. National costing report: Irritable bowel syndrome. [Internet]. February 2008a. [cited on 2021 Apr 19]; Available from: https://pubmed.ncbi.nlm.nih.gov/21656972/
Jung HK, Halder S, McNally M, et al. Overlap of gastrooesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. [Internet]. 2007. [cited on 2021 Apr 19];26(3):453-61. Available from: https://pubmed.ncbi.nlm.nih.gov/17635380/ DOI: 10.1111/j.1365-2036.2007.03366.x.
Sainsbury A, Ford A. Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol. [Internet]. 2011. [cited on 2021 Apr 19];4(2):115-27. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105621/ doi: 10.1177/1756283X10387203.
National Institute for Health and Clinical Excellence. Irritable bowel syndrome in adults: diagnosis and management. Clinical guideline CG061. [Internet]. February 2008. [cited on 2021 Apr 19]; Updated February 2015. Available from: https://www.nice.org.uk/guidance/cg61
Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. [Internet]. 2015. [cited on 2021 Apr 19];50(1):11-30. Available from: https://pubmed.ncbi.nlm.nih.gov/25500976/ DOI: 10.1007/s00535-014-1017-0.
Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. [Internet]. 2014. [cited on 2021 Apr 19];109 Suppl 1:S2-26. Available from: https://pubmed.ncbi.nlm.nih.gov/25091148/ DOI: 10.1038/ajg.2014.187.
Srimadvagbhata. Astanga Hridayam. Tripathi B, editor. Delhi: Chaukhamba Sanskrit Pratisthan; 2009. p. 487.
Agnivesha. Charaka Samhita. Acharya YT, editor. Varanasi: Chaukhamba Prakashan; 2013. p. 517.
Agnivesha. Charaka Samhita. Acharya YT, editor. Varanasi: Chaukhamba Prakashan; 2013. p. 517-18.
Agnivesha. Charaka Samhita. Acharya YT, editor. Varanasi: Chaukhamba Prakashan; 2013. p. 517-19.
Hanumant N, Lakhan MR, Jitender K, Prasanth D, Santoshkumar B. Management of Irritable Bowel Syndrome Through Ayurveda: A Case Study. International Journal of Ayurveda and Pharma Research. [Internet]. 2019[cited on 2021 Apr 19];7(6):40-44. Available from: https://ijapr.in/index.php/ijapr/article/view/1209
Wilkins T, Pepitone C, Alex B, Schade RR. Diagnosis and management of IBS in adults. Am Fam Physician. [Internet]. 2012 [cited on 2021 Apr 19];86(5):419–426. Available from: https://pubmed.ncbi.nlm.nih.gov/22963061/
Agnivesha. Charaka Samhita. Acharya YT, editor. Varanasi: Chaukhamba Prakashan; 2013. p. 518.
Sen GD. Bhaisajya Ratnavali. Mishra SN, editor. Varanasi: Chaukhambha Surbharati Prakashan; 2011. p. 361.
Sen GD. Bhaisajya Ratnavali. Mishra SN, editor. Varanasi: Chaukhambha Surbharati Prakashan; 2011. p. 253.
Sharma S. Rasa Tarangini. Shastri K, editor, 11 ed. Delhi: Motilal Banarasidas; 1989. p.288
Sen GD. Bhaisajya Ratnavali. Mishra SN, editor. Varanasi: Chaukhambha Surbharati Prakashan; 2011. p. 259.
Kumari S, Tewari PV. Yoga Ratnakara. Varanasi: Chaukhamba Bharati Academy; 2010, p. 228
Sharma PC, Yelne MB, Dennis TJ, Joshi A. Vol. 1. New Delhi: Central Council for Research in Ayurveda and Siddha, Dept of ISM and H, Min. of Health and Family Welfare, Government of India; 2001. Database on Medicinal Plants Used in Ayurveda; p. 79. [Google Scholar]
Xu Y, Wang C, Klabnik JJ, O'Donnell JM. Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment. Curr Neuropharmacol. [Internet]. 2014. [cited on 2021 Apr 19]; 12(2):108-19. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964743/ doi: 10.2174/1570159X11666131120231448
Agnivesha. Charaka Samhita. Acharya YT, editor. Varanasi: Chaukhamba Prakashan; 2013. p. 16.
Department of AYUSH. Vol. 3. New Delhi: Ministry of Health and Family Welfare; [Internet]. 2001. [cited on 2021 Apr 19]; Data base of Indian Medicinal Plants- Government of India; p. 562. e book. [Google Scholar]
Uebaba K, Xu FH, Ogawa H, TatsuseT, Wang BH, Hisajima T, Venkatraman S. Psychoneuroimmunologic effects of Ayurvedic oil-dripping treatment. J Altern Complement Med. [Internet]. 2008 Dec. [cited on 2021 Apr 19];14(10):1189-98. Available from: https://www.researchgate.net/publication/310843741_THERAPEUTIC_EFFICACY_OF_SHIRODHARA_IN_PSYCHOSOMATIC_DISOSRDES. doi: 10.1089/acm.2008.0273.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Vijayendra G Bhat, Prashant Basnet, Aniruddha Saralaya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
IJATM follows the following Terms and License of the manuscript under Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) where Author and Journal are can Share — copy and redistribute the material in any medium or format and Adapt — remix, transform, and build upon the material, and it is Non-Commercial.
